|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Osborn AG, Salzman KL, Thurnher MM, Rees
JH and Castillo M: The new World Health Organization Classification
of Central Nervous System Tumors: What can the neuroradiologist
really say? AJNR Am J Neuroradiol. 33:795–802. 2012. View Article : Google Scholar
|
|
3
|
Furnari FB, Fenton T, Bachoo RM, Mukasa A,
Stommel JM, Stegh A, Hahn WC, Ligon KL, Louis DN, Brennan C, et al:
Malignant astrocytic glioma: Genetics, biology, and paths to
treatment. Genes Dev. 21:2683–2710. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kim VN: Small RNAs: Classification,
biogenesis, and function. Mol Cells. 19:1–15. 2005.PubMed/NCBI
|
|
6
|
Shenouda SK and Alahari SK: MicroRNA
function in cancer: Oncogene or a tumor suppressor? Cancer
Metastasis Rev. 28:369–378. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chu H, Chen X, Wang H, Du Y, Wang Y, Zang
W, Li P, Li J, Chang J, Zhao G and Zhang G: MiR-495 regulates
proliferation and migration in NSCLC by targeting MTA3. Tumour
Biol. 35:3487–3494. 2014. View Article : Google Scholar
|
|
8
|
Li Z, Cao Y, Jie Z, Liu Y, Li Y, Li J, Zhu
G, Liu Z, Tu Y, Peng G, et al: MiR-495 and miR-551a inhibit the
migration and invasion of human gastric cancer cells by directly
interacting with PRL-3. Cancer Lett. 323:41–47. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jiang X, Huang H, Li Z, He C, Li Y, Chen
P, Gurbuxani S, Arnovitz S, Hong GM, Price C, et al: MiR-495 is a
tumor-suppressor microRNA down-regulated in MLL-rearranged
leukemia. Proc Natl Acad Sci USA. 109:19397–19402. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang W, Wu S, Shi Y, Miao Y, Luo X, Ji M,
Yao K and He J: c-MYB regulates cell growth and DNA damage repair
through modulating MiR-143. FEBS Lett. 589:555–564. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liang J, Liu X, Xue H, Qiu B, Wei B and
Sun K: MicroRNA-103a inhibits gastric cancer cell proliferation,
migration and invasion by targeting c-Myb. Cell Prolif. 48:78–85.
2015. View Article : Google Scholar
|
|
13
|
Yang K, He M, Cai Z, Ni C, Deng J, Ta N,
Xu J and Zheng J: A decrease in miR-150 regulates the malignancy of
pancreatic cancer by targeting c-Myb and MUC4. Pancreas.
44:370–379. 2015.
|
|
14
|
Mets E, Van der Meulen J, Van Peer G,
Boice M, Mestdagh P, Van de Walle I, Lammens T, Goossens S, De
Moerloose B, Benoit Y, et al: MicroRNA-193b-3p acts as a tumor
suppressor by targeting the MYB oncogene in T-cell acute
lymphoblastic leukemia. Leukemia. 29:798–806. 2015. View Article : Google Scholar
|
|
15
|
Claes A, Idema AJ and Wesseling P: Diffuse
glioma growth: A guerilla war. Acta Neuropathol. 114:443–458. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huse JT and Holland EC: Targeting brain
cancer: Advances in the molecular pathology of malignant glioma and
medulloblastoma. Nat Rev Cancer. 10:319–331. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hoelzinger DB, Demuth T and Berens ME:
Autocrine factors that sustain glioma invasion and paracrine
biology in the brain micro-environment. J Natl Cancer Inst.
99:1583–1593. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang J, Gong X, Tian K, Chen D, Sun J,
Wang G and Guo M: MiR-25 promotes glioma cell proliferation by
targeting CDKN1C. Biomed Pharmacother. 71:7–14. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xu D, Ma P, Gao G, Gui Y, Niu X and Jin B:
MicroRNA-383 expression regulates proliferation, migration,
invasion, and apoptosis in human glioma cells. Tumour Biol.
36:7743–7753. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sun JY, Xiao WZ, Wang F, Wang YQ, Zhu YH,
Wu YF, Miao ZL and Lin YC: MicroRNA-320 inhibits cell proliferation
in glioma by targeting E2F1. Mol Med Rep. 12:2355–2359.
2015.PubMed/NCBI
|
|
21
|
Cai W, Li Q, Yang Z, Miao X, Wen Y, Huang
S and Ouyang J: Expression of p53 upregulated modulator of
apoptosis (PUMA) and C-myb in gallbladder adenocarcinoma and their
pathological significance. Clin Transl Oncol. 15:818–824. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen RX, Xia YH, Xue TC and Ye SL:
Transcription factor c-Myb promotes the invasion of hepatocellular
carcinoma cells via increasing osteopontin expression. J Exp Clin
Cancer Res. 29:1722010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lu H, Wang Y, Huang Y, Shi H, Xue Q, Yang
S, He S and Wang H: Expression and prognostic role of c-Myb as a
novel cell cycle protein in esophageal squamous cell carcinoma.
Clin Transl Oncol. 15:796–801. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tang R, Li J, Yue M, Liu Z, Feng S, Tang S
and Wang T: A correlation analysis of miRNA-34a and its predicted
target genes in leukemia. Mol Med Rep. 9:1283–1288. 2014.PubMed/NCBI
|
